Table 2 Treatment outcome of the PDT and LEEP in the cervical HSIL.
PDT | LEEP | p value | |
|---|---|---|---|
HPV substyle eradication rate %(n) | 0.344 | ||
Single HPV16/18 | 88.2 (15/17) | 91.3 (21/23) | |
Other HR-HPV | 95.8 (23/24) | 83.3 (20/24) | |
HPV16 / 18 combined with other HR-HPV | 90.9 (10/11) | 100.0 (5/5) | |
Clearance rate of HPV infection% (n) | |||
3rd-6th months | 76.9 (40/52) | 69.2 (36/52) | 0.508 |
10th-12th months | 88.9 (40/45) | 93.5 (43/46) | 0.687 |
24th months | 95.5 (21/22) | 95.8 (23/24) | 1.000 |
Negative conversion ratio of cytology% (n) | |||
3rd-6th months | 89.5 (34/38) | 75.0 (24/32) | 0.2 |
10th-12th months | 97.0 (32/33) | 100.0 (27/27) | 1.000 |
24th months | 100.0 (22/22) | 100.0 (24/24) | |
Cure rate at 3rd-6th months % (n) | 1.000 | ||
CR | 98.1 (51/52) | 98.1 (51/52) | |
Stabilization | 1.9 (1/52) | 1.9 (1/52) | |
Cure rate at 10th-12th months % (n) | |||
CR | 100.0 (45/45) | 100.0 (46/46) | |
Stabilization | 0.0 (0/45) | 0.0 (0/46) | |
Cure rate at 24th months % (n) | |||
CR | 100.0 (22/22) | 100.0 (24/24) | |
Stabilization | 0.0 (0/22) | 0.0 (0/24) | |
